Research LettersResistance of t(11;18) positive gastric mucosa-associated lymphoid tissue lymphoma to Helicobacter pylori eradication therapy
References (5)
- et al.
Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori.
Lancet
(1993) - et al.
The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t(11;18)(q21;q21) associated with mucosa-associated lymphoid tissue lymphomas
Blood
(1999)
There are more references available in the full text version of this article.
Cited by (401)
Comparison of high and low molecular weight chitosan as in-vitro boosting agent for photodynamic therapy against Helicobacter pylori using methylene blue and endoscopic light
2019, Photodiagnosis and Photodynamic TherapyCitation Excerpt :Helicobacter pylori(H. pylori) in the stomach causes stomach cancer, chronic gastritis, and gastric ulcers. At present, the treatments for H. pylori infection are based on antibiotics and proton pump inhibitors, but the failure rate gradually increases because of the appearance of a resistant strain, intolerance to medication, or recurrent infection [1–5]. Therefore, another elimination method is needed to overcome these problems.
Gastric MALT lymphoma and Helicobacter pylori
2019, Medicina ClinicaNon-Hodgkin Lymphomas
2019, Abeloff’s Clinical OncologyH pylori-Negative MALT-Associated Extranodal Marginal Zone Lymphoma: A Comprehensive Case Report and Literature Review
2024, Journal of Investigative Medicine High Impact Case ReportsGuideline for the diagnosis and management of marginal zone lymphomas: A British Society of Haematology Guideline
2024, British Journal of Haematology
Copyright © 2001 Elsevier Ltd. All rights reserved.